- Home
- CVRX vs CDXS Comparison
CVRX vs CDXS Comparison
Compare CVRX & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- CDXS
- Stock Information
- Founded
- CVRX 2000
- CDXS 2002
- Country
- CVRX United States
- CDXS United States
- Employees
- CVRX N/A
- CDXS N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CDXS Major Chemicals
- Sector
- CVRX Health Care
- CDXS Industrials
- Exchange
- CVRX Nasdaq
- CDXS Nasdaq
- Market Cap
- CVRX 203.9M
- CDXS 216.6M
- IPO Year
- CVRX 2021
- CDXS 2010
- Fundamental
- Price
- CVRX $9.11
- CDXS $2.64
- Analyst Decision
- CVRX Buy
- CDXS Buy
- Analyst Count
- CVRX 7
- CDXS 2
- Target Price
- CVRX $14.00
- CDXS $11.00
- AVG Volume (30 Days)
- CVRX 202.9K
- CDXS 517.3K
- Earning Date
- CVRX 10-28-2025
- CDXS 10-30-2025
- Dividend Yield
- CVRX N/A
- CDXS N/A
- EPS Growth
- CVRX N/A
- CDXS N/A
- EPS
- CVRX N/A
- CDXS N/A
- Revenue
- CVRX $54,652,000.00
- CDXS $57,164,000.00
- Revenue This Year
- CVRX $11.32
- CDXS $12.88
- Revenue Next Year
- CVRX $18.58
- CDXS $21.64
- P/E Ratio
- CVRX N/A
- CDXS N/A
- Revenue Growth
- CVRX 23.11
- CDXS N/A
- 52 Week Low
- CVRX $4.30
- CDXS $1.90
- 52 Week High
- CVRX $18.55
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- CVRX 66.69
- CDXS 52.60
- Support Level
- CVRX $8.56
- CDXS $2.51
- Resistance Level
- CVRX $8.94
- CDXS $2.73
- Average True Range (ATR)
- CVRX 0.41
- CDXS 0.11
- MACD
- CVRX 0.14
- CDXS 0.03
- Stochastic Oscillator
- CVRX 91.84
- CDXS 56.80
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.